LT - 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS
EN - 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07D 213/74 |
|
|
|
C07D 401/06 |
|
|
|
C07D 401/14 |
|
|
|
C07D 413/14 |
|
|
|
C07D 401/04 |
|
|
|
C07D 413/04 |
|
|
|
C07D 417/04 |
|
|
|
C07D 417/14 |
|
|
|
A61K 31/4427 |
|
|
|
A61P 9/00 |
|
European patent
(11) |
Number of the document |
3526198 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
17788068.9 |
|
Date of filing the European patent application |
2017-10-12 |
(97) |
Date of publication of the European application |
2019-08-21 |
(45) |
Date of publication and mention of the grant of the patent |
2020-08-12
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/US2017/056265 |
|
Date |
2017-10-12 |
PCT application publication
(87) |
Number |
WO 2018/071622 |
|
Date |
2018-04-19 |
Priority applications
(30) |
Number |
Date |
Country code |
|
201662408272 P |
2016-10-14
|
US |
Inventors
(72) |
RICHTER, Jeremy M., US
BATES, J. Alex, US
|
Grantee
(73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
Title
(54) |
3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS |
|
3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS |